Improving In Vitro Test Methods for Nasal Drug Products
In this article, Mark Copley, Chief Executive Officer, and Anna Sipitanou, Business Development Manager, both of Copley Scientific, look at how in vitro testing is being refined for greater repeatability and to maximise its value as a low-cost tool for product development, including an assessment of the role of automation in improving the sensitivity of in vitro testing.
